It also calls for baseline labs covering fasting glucose, creatinine and eGFR, liver enzymes, a lipid panel and electrolytes, with follow-up roughly every three months, because sustained high protein intake alongside GLP-1 therapy can move kidney markers in susceptible people
This could make obesity treatment as personalized as cancer care
Berry and Citrus Phenolic Compounds Inhibit Dipeptidyl Peptidase IV: Implications in Diabetes Management
The dose increases typically occur every four weeks, and many people find their optimal dose somewhere in the middle of the range rather than necessarily at the maximum
Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study
Theres a two-way street between hormones and obesity